Under liquidation, owners and financials
CVR: 26277779
DKK -397,188
Gross profit
Net result: DKK -719,666
Lars Grønborg Eskesen (5-9,99%), Thue Walter Schwartz (10-14,99%)
4 more
CVR · view owners
Jakob Mosegaard Larsen
CVR · view management
Under liquidation
Founded 28 September 2001
CVR · view overview
0 employees
Annual report 2025 · average
Director registered: Jakob Mosegaard Larsen
CVR · 23/03/2026
View the full event history
NORDIC BIOTECH INCENTIVE ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Lars Grønborg Eskesen, Thue Walter Schwartz and CADENZA PARTNERS ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -397,188 and a net result of DKK -719,666 compared with DKK 4,871,034 the year before. Equity in the 2025 report amounted to DKK 5,834,302.
Selskabets formål er at være klasse B begrænset partner investor i Nordic Biotech K/S.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -397 t. | -720 t. | 6.1 mio. | 5.8 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | -243 t. | 4.9 mio. | 6.8 mio. | 6.6 mio. | - | |
| 202301/01/2023 – 31/12/2023 | 133 t. | -36 t. | 1.7 mio. | 1.7 mio. | - | |
| 202201/01/2022 – 31/12/2022 | -18 t. | -2.3 mio. | 1.7 mio. | 1.7 mio. | 0 | |
| 202101/01/2021 – 31/12/2021 | -15 t. | -338 t. | 4 mio. | 4 mio. | 0 | |
| 202001/01/2020 – 31/12/2020 | -17 t. | -87 t. | 4.3 mio. | 4.3 mio. | - | |
| 201901/01/2019 – 31/12/2019 | -29 t. | 624 t. | 4.4 mio. | 4.4 mio. | - | |
| 201801/01/2018 – 31/12/2018 | -43 t. | -23.1 mio. | 3.8 mio. | 3.8 mio. | 0 | |
| 201701/01/2017 – 31/12/2017 | 51.1 mio. | 5.3 mio. | 27 mio. | 26.9 mio. | - | |
| 201601/01/2016 – 31/12/2016 | -21 t. | -58.3 mio. | 72.6 mio. | 72.6 mio. | - | |
| 201501/01/2015 – 31/12/2015 | -20 t. | 24.2 mio. | 130.9 mio. | 130.9 mio. | - | |
| 201401/01/2014 – 31/12/2014 | -16 t. | 86.1 mio. | 106.8 mio. | 106.7 mio. | - | |
| 201301/01/2013 – 31/12/2013 | -12 t. | 12.5 mio. | 20.6 mio. | 20.6 mio. | - | |
| 201201/01/2012 – 31/12/2012 | - | 7.9 mio. | 8.1 mio. | 8.1 mio. | - |
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNORDIC BIOTECH INCENTIVE ApS is registered in the Danish CVR register with the status Under liquidation.
The CVR number of NORDIC BIOTECH INCENTIVE ApS is 26277779.
The owners of NORDIC BIOTECH INCENTIVE ApS include Lars Grønborg Eskesen, Thue Walter Schwartz and CADENZA PARTNERS ApS.
The management of NORDIC BIOTECH INCENTIVE ApS consists of Jakob Mosegaard Larsen.
In 2025, NORDIC BIOTECH INCENTIVE ApS reported a gross profit of DKK -397,188.
NORDIC BIOTECH INCENTIVE ApS had an average of 0 employees in the 2025 financial year according to the annual report.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2025. Gross profit came to DKK -397,188, and the net result was DKK -719,666.
On March 24, 2026, NORDIC BIOTECH INCENTIVE ApS entered liquidation.
As of March 23, 2026, Jakob Mosegaard Larsen is registered as liquidator of NORDIC BIOTECH INCENTIVE ApS.
As of March 23, 2026, Florian Schønharting has stepped down as director of NORDIC BIOTECH INCENTIVE ApS.
On March 23, 2026, NORDIC BIOTECH INCENTIVE ApS entered liquidation.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2024. Gross profit came to DKK -243,054, and the net result was DKK 4,871,034.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2023. Gross profit came to DKK 133,444, and the net result was DKK -35,522.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2022. Gross profit came to DKK -17,993, and the net result was DKK -2,261,727.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2021. Gross profit came to DKK -15,250, and the net result was DKK -338,359.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2020. Gross profit came to DKK -17,469, and the net result was DKK -87,438.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2019. Gross profit came to DKK -29,250, and the net result was DKK 624,101.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2018. Gross profit came to DKK -43,125, and the net result was DKK -23,115,442.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2017. Gross profit came to DKK 51,133,497, and the net result was DKK 5,256,705.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2016. Gross profit came to DKK -21,250, and the net result was DKK -58,338,775.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2015. Gross profit came to DKK -20,000, and the net result was DKK 24,178,408.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2013. Gross profit came to DKK -12,155, and the net result was DKK 12,507,308.
As of June 20, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NORDIC BIOTECH INCENTIVE ApS.
As of June 20, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH INCENTIVE ApS.
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2012. The net result was DKK 7,926,490.
As of July 18, 2012, KASTAN ApS is registered as an owner of NORDIC BIOTECH INCENTIVE ApS with an ownership share of 20%.
As of May 30, 2012, Christian Karsten Hansen has left the board of directors of NORDIC BIOTECH INCENTIVE ApS.
As of May 30, 2012, Florian Schønharting has left the board of directors of NORDIC BIOTECH INCENTIVE ApS.
As of May 30, 2012, Florian Schønharting is registered as director of NORDIC BIOTECH INCENTIVE ApS.
As of May 3, 2011, JUT NR. 2180 A/S has been appointed auditor of NORDIC BIOTECH INCENTIVE ApS.
As of May 3, 2011, EY Danmark A/S has stepped down as auditor of NORDIC BIOTECH INCENTIVE ApS.
As of September 27, 2009, is registered as an owner of NORDIC BIOTECH INCENTIVE ApS with an ownership share of 5%.
As of September 21, 2006, C. HANSEN INVEST ApS is registered as an owner of NORDIC BIOTECH INCENTIVE ApS with an ownership share of 15%.
As of May 31, 2005, Thue Walter Schwartz is registered as an owner of NORDIC BIOTECH INCENTIVE ApS with an ownership share of 10%.
As of May 31, 2005, CADENZA PARTNERS ApS is registered as an owner of NORDIC BIOTECH INCENTIVE ApS with an ownership share of 10%.
As of May 1, 2003, Lars Grønborg Eskesen is registered as an owner of NORDIC BIOTECH INCENTIVE ApS with an ownership share of 5%.
As of April 1, 2003, Christian Karsten Hansen has joined the board of directors of NORDIC BIOTECH INCENTIVE ApS.
As of April 1, 2003, Florian Schønharting has joined the board of directors of NORDIC BIOTECH INCENTIVE ApS.
As of October 3, 2001, EY Danmark A/S has been appointed auditor of NORDIC BIOTECH INCENTIVE ApS.
NORDIC BIOTECH INCENTIVE ApS was founded on September 28, 2001.
Companies in the same industry and area
CVR 10370671
CVR 31065372
CVR 33596200
CVR 37033553
CVR 27130860
